Concepedia

Douglas K. Kelsey

DK

38

Publications

4.9K

Citations

30

H-Index

1976

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Utah

Massachusetts General Hospital

New York University

Indiana University – Purdue University Indianapolis

Douglas K. Kelsey is an author at Eli Lilly (United States) specializing in medicine, social sciences, and psychiatry.

Top concepts

Publications per year

1976–2013

38

Publications

38

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

David Michelson, Lenard A. Adler, Thomas Spencer et al. · Biological Psychiatry · 2003 · 787 citations

, , +7

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 668 citations

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

David Michelson, Albert J. Allen, Joan Busner et al. · American Journal of Psychiatry · 2002 · 598 citations

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial

Douglas K. Kelsey, Calvin R. Sumner, Charles D. Casat et al. · PEDIATRICS · 2004 · 467 citations

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

A.J. Allen, Roger Kurlan, Donald L. Gilbert et al. · Neurology · 2005 · 226 citations

Rows per page

1–5 of 38